Why the study?
The study was conducted to analyze temporal trends in cardiovascular-related deaths among patients with hematological cancers in the United States from 1999 to 2020 across age, gender, and cancer type.
Population
88,146 decedents with cardiovascular primary cause of death and hematologic disease
Comparison
Trends across sex, age, race, Latino origin, and hematological cancer type
Design
Database analysis of Multiple Cause of Death records
Authors
Loading...
CV mortality declined in hematologic cancers; leaves open drivers of trends and need for prospective prevention studies.
Cardiovascular mortality among patients with hematological malignancies in the US has significantly decreased over the past two decades, although disparities exist and hypertension-related mortality is rising.
Doolub et al. (2025) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: